Vaxxinity, Inc. 4 SEC Filings

Filed On	Filing
29 Apr 2024	Form 4: Ray Sumita, Chief Legal, Comp & Admin Off Granted 425,000 Employee Stock option (right to buy)
03 Nov 2023	Form 4: Paula Molina Rene, See Remarks
11 Oct 2023	Form 4: Powchik Peter, Director Granted 159,744 Stock option (right to buy)
08 Sep 2023	Form 4: Prime Movers Lab Fund I Lp, 10% owner and 1 other Sold 10,147 shares ($19.1K) · Sold 27,037 shares ($48.3K) · Sold 11,791 shares ($21.1K) · 2 more
26 Jun 2023	Form 4: Hornig George R, Director Granted 132,352 Stock option (right to buy)
26 Jun 2023	Form 4: Smith James Alan, Director Granted 132,352 Stock option (right to buy)
26 Jun 2023	Form 4: Ogilvie Landon E, Director Granted 132,352 Stock option (right to buy)
26 Jun 2023	Form 4: Eade Katherine A., Director Granted 132,352 Stock option (right to buy)
26 Jun 2023	Form 4: Toledano Gabrielle B, Director Granted 132,352 Stock option (right to buy)
26 Jun 2023	Form 4: Diamandis Peter, Director Granted 132,352 Stock option (right to buy)
26 Jun 2023	Form 4: Powchik Peter, Director Granted 132,352 Stock option (right to buy)
02 May 2023	Form 4: Diamandis Peter, Director Received 475,537 shares by exercise or conversion ($301K)
05 Apr 2023	Form 4: Hu Mei Mei, Director Granted 693,928 Stock Option (right to buy)
05 Apr 2023	Form 4: Reese Lou, Director Granted 982,795 Stock Option (right to buy)
04 Apr 2023	Form 4: Pesile Jason, See Remarks Granted 32,700 Stock Option (right to buy)
04 Apr 2023	Form 4: Paula Molina Rene, See Remarks Granted 116,612 Stock Option (right to buy)
04 Apr 2023	Form 4: Palm Ulo, See Remarks Granted 123,418 Stock Option (right to buy)
25 Jan 2023	Form 4: Prime Movers Lab Fund I Lp, 10% owner and 1 other Sold 500,692 shares ($1.68M)
05 Dec 2022	Form 4: Prime Movers Lab Fund I Lp, 10% owner and 1 other Sold 334,807 shares ($995K) · Sold 13,741 shares ($35.3K)
08 Sep 2022	Form 4: Prime Movers Lab Fund I Lp, 10% owner and 1 other Sold 37,358 shares ($89.8K)

Comments